| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/25/2005 | CN1203093C Method for producing whole silkworm powder milk-containing and ferritin |
| 05/25/2005 | CN1203092C Process for preparing transgenic coat producing milk containing human granulocyte-colony stimulating factor |
| 05/25/2005 | CN1202862C Compsns. comprising comjugates of stable, active, human OB protein with antibody Fc chain and methods |
| 05/25/2005 | CA2448831A1 Multi-stage cascade boosting vaccine |
| 05/24/2005 | US6897359 Carnation antisense deoxyhypusine synthase molecule and method of inhibiting deoxyhypusine synthase expression in plants |
| 05/24/2005 | US6897358 For altering any starch-storing plant, preferably cereals, in particular wheat, so that it synthesizes a modified starch |
| 05/24/2005 | US6897357 Characterization of phenylalanine ammonia-lyase (PAL) gene in wounded lettuce tissue |
| 05/24/2005 | US6897356 Thioredoxin H homologs |
| 05/24/2005 | US6897353 Yeast-Bacteria shuttle vector |
| 05/24/2005 | US6897352 Detecting agent for use in reducing or preventing ultraviolet radiation damage; obtain transgenic rodent, expose to ultraviolet radiation, administer modulating agent, monitor rodent cell for reduced cellular damage |
| 05/24/2005 | US6897300 Nicotianamine aminotransferase and gene therefor |
| 05/24/2005 | US6897296 Antibody that specifically binds an Mch5 polypeptide |
| 05/24/2005 | US6897294 Inhibitors of vascular endothelial growth factor activity, their uses and processes for their production |
| 05/24/2005 | US6897293 A DNA sequence encoding a gax protein or portion, which inhibits vascular smooth muscle cell proliferation, useful in the treatment of blood vessel diseases |
| 05/24/2005 | US6897292 For detecting a genetic abnormality, cancer |
| 05/24/2005 | US6897291 For drug screening agonists/antagonists; for germ cell development/fertilization; amphibian oocyte expression |
| 05/24/2005 | US6897290 Regulators of complement activation (RCA); diagnosis/therapy of complement system for autoimmune disease treatment; open reading frames; point mutations; membrane cofactor/decay accelerating factor/factor H |
| 05/24/2005 | US6897069 System and method for electroporating a sample |
| 05/24/2005 | US6897067 Surface transfection and expression procedure |
| 05/24/2005 | US6897066 For diagnosis/therapy of human genetic disorders; in situ genetic engineering/cloning |
| 05/24/2005 | US6897063 Accessory functions for use in recombinant AAV virion production |
| 05/24/2005 | US6897057 Cell-specific and/or tumor-specific promoter retargeting of herpes γ 34.5 gene expression |
| 05/24/2005 | US6897056 32544, a novel human phospholipase C and uses thereof |
| 05/24/2005 | US6897054 For controlling in vitro cell proliferation; genetic engineering |
| 05/24/2005 | US6897050 Desaturase genes and their use |
| 05/24/2005 | US6897048 Microorganisms and method for L-arginine production by fermentation |
| 05/24/2005 | US6897045 Adeno-associated virus vectors |
| 05/24/2005 | US6897044 Drugs for treatment of cancer/autoimmune disorders; apoptosis promoters |
| 05/24/2005 | US6897043 Nucleotide sequences for use as efficient gene transfer and cloning tool in genetic engineering |
| 05/24/2005 | US6897042 Low-temperature inducible expression vector |
| 05/24/2005 | US6897041 For treating/preventing staphylococcal infections; transcription regulators; ion exchange resins; bacteriophages; genetic engineering/cloning |
| 05/24/2005 | US6897040 Methods and host cells for improved cell culture |
| 05/24/2005 | US6897039 For treatment of cardiovascular diseases. |
| 05/24/2005 | US6897033 Fungal lipase |
| 05/24/2005 | US6897030 CDNA sequence encoding porcine brain natriuretic peptide and related genes encoding canine and human peptides with natriuretic activity are disclosed. The gene is shown to make accessible the DNAs encoding analogous natriuretic peptides in |
| 05/24/2005 | US6897029 For drug screening anticancer agents; genetic engineering; differential isoform splicing |
| 05/24/2005 | US6897028 For drug screening/production; consensus sequences; blot analysis; chromatography; electrophoresis |
| 05/24/2005 | US6897023 Method for determining relative abundance of nucleic acid sequences |
| 05/24/2005 | US6897020 Methods and compositions for elucidating relative protein expression levels in cells |
| 05/24/2005 | US6897017 Vivo library-versus-library selection of optimized protein-protein interactions |
| 05/24/2005 | US6897016 For therapy of diseases using ribozymes; splicing/genetic engineering; chimeric nucleic acids/proteins |
| 05/24/2005 | US6896887 Binding of a proteinaceous substance to cell-wall material of a Gram-positive bacterium |
| 05/24/2005 | US6896884 Human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases |
| 05/24/2005 | US6896882 Breaking peptidoglycans in cell wall; destroying genomes |
| 05/24/2005 | US6896880 Interleukins; osteoporosis therapy |
| 05/24/2005 | CA2123875C Hepatitis-c virus testing |
| 05/24/2005 | CA2100334C Process for preparing daunorubicin |
| 05/24/2005 | CA2037607C Humanised antibodies |
| 05/24/2005 | CA1341484C Tissue plasminogen activator having zymogenic or fibrin specific properties |
| 05/20/2005 | WO2005024007A8 Use of pks 13 protein coding for condensase of mycolic acids of mycobacteria and related strains as an antibiotics target |
| 05/20/2005 | CA2487657A1 Specific markers for metabolic syndrome |
| 05/19/2005 | WO2005045072A1 Cst (compartmentalised self tagging) |
| 05/19/2005 | WO2005045071A1 Methods of identifying active genes |
| 05/19/2005 | WO2005045064A1 Screening method with the use of tbk1 knockout mouse |
| 05/19/2005 | WO2005045046A1 Expression of plastid-targeted polypeptides in plants |
| 05/19/2005 | WO2005045045A2 Recombinant microorganism |
| 05/19/2005 | WO2005045041A2 Rna interference mediated inhibition of cholesteryl ester transfer protein (cetp) gene expression using short interfering nucleic acid (sina) |
| 05/19/2005 | WO2005045040A2 RNA INTERFERANCE MEDIATED INHIBITION OF CHOLINERGIC MUSCARINIC RECEPTOR (CHRM3) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID /siNA) |
| 05/19/2005 | WO2005045039A2 RNA INTERFERENCE MEDIATED INHIBITION OF INTERCELLULAR ADHESION MOLECULE (ICAM) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 05/19/2005 | WO2005045038A2 RNA INTERFERENCE MEDIATED INHIBITION OF GPRA AND AAA1 GENE EXPRESSION USING SHORT NUCLEIC ACID (siNA) |
| 05/19/2005 | WO2005045037A2 RNA INTERFERENCE MEDIATED INHIBITION OF 5-ALPHA REDUCTASE AND ANDROGEN RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 05/19/2005 | WO2005045036A2 Rna interference mediated inhibition of hairless (hr) gene expression using short interfering nucleic acid (sina) |
| 05/19/2005 | WO2005045035A2 RNA INTERFERENCE MEDIATED INHIBITION OF NOGO AND NOGO RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 05/19/2005 | WO2005045034A2 RNA INTERFERENCE MEDIATED TREATMENT OF PARKINSON DISEASE USING SHORT INTERERING NUCLEIC ACID (siNA) |
| 05/19/2005 | WO2005045033A1 Method of detecting genetic polymorphism |
| 05/19/2005 | WO2005045032A2 RNA INTERFERENCE MEDIATED INHIBITION OF EARLY GROWTH RESPONSE GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 05/19/2005 | WO2005045031A1 Method for the production of full-length dnac by ligaturation of an adapter with a cohesive xtremity |
| 05/19/2005 | WO2005045030A1 A rapid and low cost method for isolating nucleic acid |
| 05/19/2005 | WO2005045028A1 Cell-free notch cleavage analysis method and drug screening method |
| 05/19/2005 | WO2005045026A1 Insulin-expressing human islet cell lines capable of reversibly proliferating and use thereof |
| 05/19/2005 | WO2005045025A2 Cloning and characterization of 5’ flanking regions of a human aggrecanase-1 gene |
| 05/19/2005 | WO2005045024A1 Promoter in the presence of organic acid and utilization thereof |
| 05/19/2005 | WO2005045023A1 Method of concentrating and purifying nucleic acid and apparatus therefor |
| 05/19/2005 | WO2005045015A2 Polymerase |
| 05/19/2005 | WO2005045013A2 Recombinant microorganism |
| 05/19/2005 | WO2005044981A2 Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina) |
| 05/19/2005 | WO2005044976A2 Oligomeric compounds for use in gene modulation |
| 05/19/2005 | WO2005044975A2 Genes encoding carotenoid compounds |
| 05/19/2005 | WO2005044973A2 NOVEL ACETOACETYL-CoA REDUCTASE AND PROCESS FOR PRODUCING OPTICALLY ACTIVE ALCOHOL |
| 05/19/2005 | WO2005044881A1 Carrier for nucleic acid molecule delivery |
| 05/19/2005 | WO2005044843A1 Regulation of cell division and plant nodulation |
| 05/19/2005 | WO2005044300A1 Vaccine compositions which are used to control amoebiasis and which are based on the 112kda surface protein from entamoeba histolytica |
| 05/19/2005 | WO2005044282A1 Use of nucleic acids comprising an exocyclic adduct |
| 05/19/2005 | WO2005044091A2 Diagnostic and therapeutic methods and compositions involving pten and breast cancer |
| 05/19/2005 | WO2005043993A1 Transgenic amphibian models for lymphatic vessel development |
| 05/19/2005 | WO2005043992A1 Attention-deficient hyperactivity disorder (adhd) model mouse |
| 05/19/2005 | WO2005043991A1 Methods for selecting gametes and for producing genetically modified non-human animals |
| 05/19/2005 | WO2005033326A3 Method of extending single-stranded nucleic acid, single-stranded nucleic acid extending apparatus and dna chip |
| 05/19/2005 | WO2005033289A3 Transfection reagents |
| 05/19/2005 | WO2005033281A3 A process of making transgenic mammals that produce exogenous proteins in milk and transgenic mammals produced thereby |
| 05/19/2005 | WO2005028656A3 Methods and compositions for enhanced plant cell transformation |
| 05/19/2005 | WO2005026358A9 Polymorphisms in selenoprotein s |
| 05/19/2005 | WO2005024025A8 Polyene polyketides and methods of production |
| 05/19/2005 | WO2005021764A3 A process for proteolytic cleavage and purification of recombinant proteins produced in plants |
| 05/19/2005 | WO2005021762A3 A process for proteolytic cleavage and purification of recombinant proteins produced in plants |
| 05/19/2005 | WO2005019473A3 Use of silver gene for the authentication of the racial origin of animal populations, and of the derivative products thereof |
| 05/19/2005 | WO2005017162A3 Expression vectors, transformed host cells and fermentation process for the production of recombinant polypeptides |
| 05/19/2005 | WO2005017093A8 Polypeptides of streptococcus pyogenes |
| 05/19/2005 | WO2005014635A3 Secreted polypeptide species reduced in cardiovascular disorders |
| 05/19/2005 | WO2005009346A3 Inhibition of gene function by delivery of polynucleotide-based gene expression inhibitors to mammalian cells in vivo |